A capillary electrophoresis method for evaluation of Aβ proteolysis in vitro

Journal of Neuroscience Methods

Volumn 178, Issue 1, 2009, Pages 40-45

  Alper, Benjamin J ^a   Schmidt, Walter K ^a  

^a University of Georgia   (United States)

Author keywords

Alzheimer's disease; Amyloid beta; Capillary electrophoresis; Insulin degrading enzyme

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; INSULIN; INSULINASE;

ARTICLE; CAPILLARY ELECTROPHORESIS; ENZYME SUBSTRATE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMYLOID BETA-PROTEIN; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, CAPILLARY; HUMANS; INSULIN; INSULYSIN; PEPTIDE FRAGMENTS; RATS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

EID: 59249100307     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2008.11.010     Document Type: Article

References (33)

1. Bondy C., Zhou J., Chin E., and Roth R.A. Cellular distribution of insulin-degrading enzyme gene expression. Comparison with insulin and insulin-like growth factor receptors. The Journal of Clinical Investigation 93 (1994) 966-973
2. Dahlgren K.N., Manelli A.M., Stine W.B., Baker L.K., Krafft G.A., and LaDu M.J. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. Journal of Biological Chemistry 277 (2002) 32046-32053
3. Farris W., Leissring M.A., Hemming M.L., Chang A.Y., and Selkoe D.J. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid β-protein. Biochemistry 44 (2005) 6513-6525
4. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E.A., Frosch M.P., et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proceedings of the National Academy of Sciences USA 100 (2003) 4162-4167
5. Farris W., Mansourian S., Leissring M.A., Eckman E.A., Bertram L., Eckman C.B., et al. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. American Journal of Pathology 164 (2004) 1425-1434
6. Glenner G.G., and Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and Biophysical Research Communications 120 (1984) 885-890
7. Greenfield J.P., Tsai J., Gouras G.K., Hai B., Thinakaran G., Checler F., et al. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proceedings of the National Academy of Sciences USA 96 (1999) 742-747
8. Haan M.N. Therapy insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease. Nature Clinical Practice Neurology 2 (2006) 159-166
9. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
10. Janson J., Laedtke T., Parisi J.E., O'Brien P.O., Petersen R.C., and Butler P.C. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53 (2004) 474-481
11. Kurochkin I.V. Insulin-degrading enzyme: embarking on amyloid destruction. Trends in Biochemical Sciences 26 (2001) 421-425
12. Leissring M.A., Farris W., Chang A.Y., Walsh D.M., Wu X., Sun X., et al. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40 (2003) 1087-1093
13. Leissring M.A., Lu A., Condron M.M., Teplow D.B., Stein R.L., Farris W., et al. Kinetics of amyloid-beta protein degradation determined by novel fluorescence- and fluorescence polarization-based assays. Journal of Biological Chemistry 278 (2003) 37314-37320
14. Leissring M.A., and Selkoe D.J. Structural biology: enzyme target to latch on to. Nature 443 (2006) 761-762
15. McDermott J.R., and Gibson A.M. Degradation of Alzheimer's beta-amyloid protein in human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochemical Research 22 (1997) 49-56
16. Miller B.C., Eckman E.A., Sambamurti K., Dobbs N., Chow K.M., Eckman C.B., et al. Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proceedings of the National Academy of Sciences USA 100 (2003) 6221-6226
17. Mukherjee A., Song E., Kihiko-Ehmann M., Goodman J.P., St. Pyrek J., Estus S., et al. Insulysin hydrolyzes amyloid-beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques. Journal of Neuroscience 20 (2000) 8745-8749
18. Neuhaus E.B., Menon N.K., Makula R.A., and Przybyla A.E. Vydac reversed-phase columns aid in purification of recombinant Alzheimer's proteins. Vydac Advances 3 (1999) 4-5
19. Neve R.L., McPhie D.L., and Chen Y. Alzheimer's disease: a dysfunction of the amyloid precursor protein. Brain Research 886 (2000) 54-66
20. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. Journal of Biological Chemistry 273 (1998) 32730-32738
21. Sabella S., Quaglia M., Lanni C., Racchi M., Govoni S., Caccialanza G., et al. Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides. Electrophoresis 25 (2004) 3186-3194
22. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual (1989), Cold Spring Harbor Laboratory, New York
23. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359 (1992) 325-327
24. Shen Y., Joachimiak A., Rosner M.R., and Tang W.J. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 443 (2006) 870-874
25. Shoji M.G., Todd E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258 (1992) 126-129
26. Song E.S., Mukherjee A., Juliano M.A., Pyrek J.S., Goodman Jr. J.P., Juliano L., et al. Analysis of the subsite specificity of rat insulysin using fluorogenic peptide substrates. Journal of Biological Chemistry 276 (2001) 1152-1155
27. Song E.S., Daily A., Fried M.G., Juliano M.A., Juliano L., and Hersh L.B. Mutation of active site residues of insulin-degrading enzyme alters allosteric interactions. Journal of Biological Chemistry 280 (2005) 17701-17706
28. Sticht H., Bayer P., Willbold D., Dames S., Hilbich C., Beyreuther K., et al. Structure of amyloid Aβ-(1-40)-peptide of Alzheimer's disease. European Journal of Biochemistry 233 (1995) 293-298
29. Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A., St George-Hyslop P., Van Keuren M.L., et al. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235 (1987) 880-884
30. Thorsèn G., Bergquist J., Westlind-Danielsson A., and Josefsson B. Stereoselective determination of amino acids in beta-amyloid peptides and senile plaques. Analytical Chemistry 73 (2001) 2625-2631
31. Varesio E., Rudaz S., Krause K.-H., and Veuthey J.-L. Nanoscale liquid chromatography and capillary electrophoresis coupled to electrospray mass spectrometry for the detection of amyloid-β peptide related to Alzheimer's disease. Journal of Chromatography A 974 (2002) 135-142
32. Vekrellis K., Ye Z., Qiu W.Q., Walsh D., Hartley D., Chesneau V., et al. Neurons regulate extracellular levels of amyloid-beta protein via proteolysis by insulin-degrading enzyme. Journal of Neuroscience 20 (2000) 1657-1665
33. Zagorski M.G., Yang J., Haiyan S., Kan M., Zeng H., and Hong A. Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity. Methods in Enzymology 309 (1999) 189-204